Navigation Links
Anti-Cholesterol Drug May Ease Back Pain
Date:2/23/2009

Lab results suggest that Lovastatin could help with degenerative disc disease

MONDAY, Feb. 23 (HealthDay News) -- The cholesterol-lowering drug lovastatin (Mevacor) might improve outcomes for people who have surgery for degenerative disc disease, a major cause of back pain.

In an attempt to find ways to stop or reverse degenerative disc disease, orthopedic researchers have been extracting cells from disc tissue removed during surgery and cultivating the cells in the laboratory. The cells are then transferred back into patients.

In a small study, Dr. Shu-Hua Yang, chief of the department of orthopedics at National Taiwan University, and his colleagues found that lovastatin helps the differentiation of disc cells being cultivated in the lab.

The study included six people, ages 23 to 29, who were having surgery for herniated lumbar discs. The researchers removed cells from the nucleus pulposus (the jelly-like substance in the middle of a spinal disc) and added lovastatin to see if it would maximize expression of collagen II and minimize expression of collagen I, two proteins involved in bone formation.

After 72 hours, the number of nucleus pulposus cells had increased, the production of collagen II (which makes up moveable joints) had increased, and the production of collagen I (which plays a role in the development of excess fibrous connective tissues) had decreased. Lovastatin caused no harm to the nucleus pulposus cells, the researchers reported.

The findings were to be presented during the annual meeting of the Orthopaedic Research Society this week in Las Vegas.

"Regeneration of the nucleus pulposus tissue in the early stage of intervertebral disc degeneration can theoretically retard or even reverse the degenerative process and possibly regain a healthy intervertebral disc," Yang said in an American Academy of Orthopaedic Surgeons news release. "Further studies are needed to determi
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

2

GOOD

Page: 1 2

Related medicine news :

1. Anti-Cholesterol Drugs Help Prevent Lung Decline
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Anti-Cholesterol Drug May Ease Back Pain
Anti-Cholesterol Drug May Ease Back Pain
(Date:5/22/2012)... Colonoscopies helped doctors detect a high rate of ... screening for the first time, a new study ... be made available to otherwise healthy elderly people ... research fellow at Grand Rapids Medical Education Partners, ... Grand Rapids, Mich., concluded. For the study, ...
(Date:5/22/2012)... Pa. (May 22, 2012) Potentially severe hypersensitivity reactions ... mechanism, resulting from the creation of drug-induced immunogens that ... a study published online by the journal ... AIDS Society . AIDS is published by ... Wolters Kluwer Health . , The study is ...
(Date:5/22/2012)... (HealthDay News) -- Hundreds of thousands of Americans ... potentially life-threatening liver complications over the next few ... evaluated medical insurance claims data and found that ... liver disease in 2008, and estimated that another ... 2015. The risk of developing advanced liver ...
(Date:5/22/2012)... When brain cells start oozing too much of ... disease, the astrocytes that normally nourish and protect them ... is excreted by all neurons, but rates increase with ... blood, oxygen and nutrients to neurons in addition to ... inflamed by excessive amyloid. , Now researchers have ...
(Date:5/22/2012)... of Tropical Medicine, has produced proteins imitating typical parts ... in more efficient diagnostic tests, without the need for ... of Africans contract sleeping sickness. The cause is a ... bite of tsetse flies. First the parasite multiplies in ... It then lodges in organs like heart and kidneys ...
Breaking Medicine News(10 mins):Health News:Colonoscopy May Detect Curable Cancer in Elderly: Study 2Health News:Reactions to HIV drug have autoimmune cause, reports AIDS journal 2Health News:Reactions to HIV drug have autoimmune cause, reports AIDS journal 3Health News:Hepatitis C Causing Liver Damage in Greater Numbers: Study 2Health News:Neuron-nourishing cells appear to retaliate in Alzheimer's 2Health News:Better tests for sleeping sickness 2
... running at double the number of what they were 10 ... high//.,Deaths due to alcoholic liver disease had risen by 39 ... , Office for National Statistics figures compiled for ... alcoholic liver disease last year, compared to 14,400 admissions in ...
... Recent research has revealed that having several older brothers increases ... finding that adds //weight to the idea of a biological ... of Brock University in St Catharines, Canada said, "It's likely ... that there is probably a biological basis for homosexuality." ...
... by residents living near the former VA Tech Peebles ... fire which ripped// through this industrial site in 1999. ... such as eczema, asthma, psoriasis and thyroid irregularities, However ... a link between the illnesses and the factory site ...
... be associated with reduced length of antibiotic treatment for ... ,A biomarker of infection, procalcitonin appeared to ... therapy as compared with other parameters. ,The ... kind, appears in the first issue for July 2006 ...
... of health had stated on Friday that the precedent ... the Klebsiella// outbreak at Durban's Mahatma Gandhi Memorial Hospital, ... ,Thami Mseleku said, “Nobody needs to communicate these ... before 1994. It's (overcrowding and staff shortages) a known ...
... problem to surmount amidst a host of crisis health issues-that ... be left with zilch options to help its people who ... is said to be fast depleting in national referral hospitals. ... over the next couple of months. This is surely a ...
Other Medicine News:Health News:Alcohol-Related Illnesses On The Rise 2Health News:No Clue to Cause of Mystery Illnesses 2Health News:Procalcitonin-Guided Antibiotic Therapy Proved Effective in CAP Cure 2Health News:Procalcitonin-Guided Antibiotic Therapy Proved Effective in CAP Cure 3Health News:Klebsiella Outbreak In Durban Blamed On Staff Shortage & Overcrowding 2
(Date:5/22/2012)... Calif., MAY 22, 2012 ThermoGenesis Corp. (NASDAQ: ... technologies for the processing, storage and administration of cell ... Thailand for its AXP® AutoXpress® Platform (AXP) used for ... expects to initiate commercial activities in the country later ... presence in the region,s cord blood market through our ...
(Date:5/22/2012)... Mass., May 22, 2012  Halo Therapeutics, ... therapeutics for rare fibrotic diseases, announced today ... $1.1 million from 12 not-for-profit foundations serving the ... the funds to expedite the phase 2 ... for Duchenne muscular dystrophy (DMD). HT-100, a ...
(Date:5/22/2012)... 22, 2012  Systech International, a leading provider ... protect product integrity and authenticity, today announced that ... Vice President. Mr. Harty will be ... of Systech,s Cloud Products and Solutions, and aligning ... "Mr. Harty has a unique perspective of ...
Breaking Medicine Technology:ThermoGenesis Announces Axp Approval In Thailand 2ThermoGenesis Announces Axp Approval In Thailand 3Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 2Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100 3David F. Harty Joins Systech International as Vice President 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 1AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 3China Medical Technologies Announces the SFDA Approval for its SPR System 14518 1China Medical Technologies Announces the SFDA Approval for its SPR System 14518 2China Medical Technologies Announces the SFDA Approval for its SPR System 14518 3Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 1Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 2Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 3Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 4Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 5
... ATLANTA, March 24 After completing its review ... Data Safety,Monitoring Board (DSMB) has once again recommended ... collectively as the FAME(TM) (Fluocinolone,Acetonide in Diabetic Macular ... change. The trial is studying the use of ...
... treating pediatric acute lymphoblastic,leukemia combined with molecular science ... disease, MEMPHIS, Tenn., March 20 The ... for children with acute,lymphoblastic leukemia (ALL) will be ... research, according to an article,by St. Jude Children,s ...
Other Medicine Technology:DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME 2DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME 3Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers 2
Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be easily drill...
...
... perimeters are not restricted to small ... applications. These are full field capable, ... only perimeters you'll ever need to ... possible. They also include the ...
... Gore's EXCLUDER AAA Endoprosthesis is an innovative ... treatment option for patients with abdominal aortic ... durable ePTFE bifurcated graft with an outer ... device flexibility and material durability. The function ...
Medicine Products: